cGMP activates PKG. What attributes of "activated" PKG can be detected by IHC? For example, the attached paper mentions that binding of 2 cGMPs to PKG, releases the autoinhibitory domain of the R subunit domain from its interaction with the catalytic cleft of the C subunit domain. Thus, such a binding promotes autophosphorylation. Indeed, "activated" PKG is autophosphorylated. On the other hand, autophosphorylation can also lead to activation. A Similar mechanism has been suggested for PKA activation.

Does this mean that phosphorylated PKG (ser79 phospho-PKG) is actually an "activated" PKG? Is their any antibody available that detects this phosho-protein?

Alternative approach: If I use cGMP antibody for immunostaining and find that cGMP is abundantly expressed in experimental condition when compared to the control condition, can I infer that PKG is more likely to be activated in experimental condition? Can cGMP abundance be used as a surrogate marker for PKG activation?

More Tushar Deshpande's questions See All
Similar questions and discussions